TYK Medicines, Inc

HK$3.43As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2410Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 2Y CAGR (56.88%)
Div yield —
ROE (70.66%)
Biotechnology
Beta (5Y) (0.30)
PE TTM —
TSR TTM (77.61%)
Mkt cap HK$1.319B
ROIC (46.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.57
4.15%
(24.31%)
Hold 3|6|1|4|2
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.05
0.05
(12.08%)
(6.06%)
(4.23%)
1.62%
Revenue¥M
66.26
64.73
62.85
66.54
10.19%
5.84%
0.37%
0.80%
Peers (US$168.3M)
Cap (US$)
PE
173.9M
—
170.4M
—
Capital
TTM
5Y
10Y
Leveragex
0.690
(0.177)
(0.116)
EBIT/Intx
0.399
0.153
0.162
Own earn%
(85.70)
(10.92)
(16.67)
Sh yield%
16.04
14.04
14.15
Owners
Insiders/Inst%
7.28
37.47
Short interest%
4.54
SBC / revenue%
2.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
28–32
$1 testx
—
Incr. ROIC%
6